182 related articles for article (PubMed ID: 35192963)
1. Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy.
Álvarez-López P; Campos-Varela I; Quiroga S; Díez I; Charco R; Simón-Talero M; Castells L
Ann Hepatol; 2022; 27(3):100687. PubMed ID: 35192963
[TBL] [Abstract][Full Text] [Related]
2. [Endovascular therapy accompanied by spontaneous portosystemic shunts for overt hepatic encephalopathy].
Zhao T; Huang JY; Liu CH; Chen RB; Fan WL; Zheng WL
Zhonghua Gan Zang Bing Za Zhi; 2023 Feb; 31(2):181-185. PubMed ID: 37137834
[No Abstract] [Full Text] [Related]
3. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
[TBL] [Abstract][Full Text] [Related]
4. Combined Spontaneous Portosystemic Shunt Embolization and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Hepatic Encephalopathy.
Gurtatta RS; Gaba RC; Herren JL
J Vasc Interv Radiol; 2024 May; 35(5):659-663. PubMed ID: 38355039
[TBL] [Abstract][Full Text] [Related]
5. Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts.
Ke Q; Wang Z; Huang X; Li L; Wu W; Qiu L; Jiao Y; Xie Y; Peng X; Liu J; Guo W
Ann Hepatol; 2022; 27(5):100725. PubMed ID: 35623551
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
[TBL] [Abstract][Full Text] [Related]
7. Successful control of portal hypertension-related complications after two embolization procedures for multiple and large spontaneous portosystemic shunts in a patient with liver cirrhosis.
Ueno W; Sato N; Miura K; Morimoto N; Watanabe S; Nomoto H; Isoda N; Kijima S; Kikuchi T; Manaka S; Mori H; Yamamoto H
Clin J Gastroenterol; 2021 Aug; 14(4):1227-1232. PubMed ID: 33993428
[TBL] [Abstract][Full Text] [Related]
8. Treatment of refractory hepatic encephalopathy induced by spontaneous portosystemic shunt: Selective splenic vein embolization versus shunt embolization.
Zhang L; Wei B; Wang Z; Tong H; Wu H
Dig Liver Dis; 2023 Mar; 55(3):381-386. PubMed ID: 36175324
[TBL] [Abstract][Full Text] [Related]
9. Shunt occlusion for portosystemic shunt syndrome related refractory hepatic encephalopathy-A single-center experience in 21 patients from Kerala.
Philips CA; Kumar L; Augustine P
Indian J Gastroenterol; 2017 Sep; 36(5):411-419. PubMed ID: 29124669
[TBL] [Abstract][Full Text] [Related]
10. Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.
Lynn AM; Singh S; Congly SE; Khemani D; Johnson DH; Wiesner RH; Kamath PS; Andrews JC; Leise MD
Liver Transpl; 2016 Jun; 22(6):723-31. PubMed ID: 26970243
[TBL] [Abstract][Full Text] [Related]
11. Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?
Laleman W; Praktiknjo M; Lauridsen MM; Bonne L; Vanderschueren E; Verslype C; Krag A; Trebicka J; Maleux G
Metab Brain Dis; 2023 Jun; 38(5):1717-1728. PubMed ID: 36401681
[TBL] [Abstract][Full Text] [Related]
12. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
[TBL] [Abstract][Full Text] [Related]
13. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
[TBL] [Abstract][Full Text] [Related]
14. To evaluate the prevalence of spontaneous portosystemic shunts in decompensated cirrhosis patients and its prognostic significance.
Kothari R; Khanna D; Kar P
Indian J Gastroenterol; 2023 Oct; 42(5):677-685. PubMed ID: 37642937
[TBL] [Abstract][Full Text] [Related]
15. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy.
Philips CA; Rajesh S; George T; Ahamed R; Mohanan M; Augustine P
Indian J Gastroenterol; 2020 Aug; 39(4):377-387. PubMed ID: 32929684
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
18. Refractory hepatic encephalopathy due to concomitant transjugular intrahepatic portosystemic shunt and spontaneous mesocaval shunt controlled by embolization of the competitive portosystemic shunt.
Cura M
Clin Imaging; 2009; 33(3):231-3. PubMed ID: 19411031
[TBL] [Abstract][Full Text] [Related]
19. Treatment of recurrent severe hepatic encephalopathy in patients with large porto-collaterals shunts or transjugular portosystemic shunt.
Temmerman F; Laleman W; Maleux G; Nevens F
Acta Gastroenterol Belg; 2020; 83(1):67-71. PubMed ID: 32233274
[TBL] [Abstract][Full Text] [Related]
20. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy.
An J; Kim KW; Han S; Lee J; Lim YS
Aliment Pharmacol Ther; 2014 Jun; 39(12):1418-26. PubMed ID: 24754260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
